Tissue Structural Markers From X-Ray Diffraction for Early Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current non-invasive diagnostic methods for diseases like cancer are lacking in availability, cost-effectiveness, and reliability, often leading to late detection and ineffective treatment.
Innovation Solution
A method using biological tissue characterization techniques, such as X-ray diffraction, to identify structural markers in laboratory animals exposed to carcinogenic or pathogenic substances, comparing molecular structures between affected and control groups to develop diagnostic tests for early disease detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If non-invasive diagnostic methods like X-ray diffraction are used to measure tissue samples, then early disease detection capability is improved, but availability and cost-effectiveness deteriorate
Solution Approach 1:
The patent creates a reference library of diffraction patterns from tissue samples with known disease states. This reference library serves as a template that can be used to interpret diffraction patterns from clinical samples, enabling early disease detection through comparison without requiring complex real-time analysis systems in every clinical setting.
Solution Approach 2:
The patent performs preliminary measurements and characterizations on tissue samples to establish baseline diffraction patterns and structural markers before clinical application. By pre-characterizing tissue structures and disease-associated changes in a controlled setting, the method enables faster, more reliable clinical diagnostics without repeating all characterization steps.
2Object-affected harmful factors
If non-invasive diagnostic methods are used, then patient comfort and safety are improved, but measurement precision and reliability deteriorate
Solution Approach 1:
The patent measures multiple parameters from diffraction patterns including structural markers, periodicity, orientation, and intensity distributions. By analyzing multiple parameters simultaneously rather than relying on a single measurement, the method achieves high measurement precision while maintaining non-invasive patient safety.
Solution Approach 2:
The patent replaces invasive mechanical tissue sampling with non-invasive X-ray diffraction measurement. The diffraction technique provides molecular-level structural information about biological tissues without physical contact or tissue removal, substituting a gentle optical/measurement-based system for aggressive mechanical sampling while maintaining or improving diagnostic precision.
3Measurement precision
If structural markers are identified through comparative analysis of diffraction patterns, then diagnostic accuracy is improved, but device complexity and analysis time increase
Solution Approach 1:
The patent extracts specific structural markers and characteristic features from complex diffraction patterns. By identifying and isolating key parameters such as periodicity, orientation, and intensity ratios that are indicative of disease states, the method simplifies the analysis process while maintaining high diagnostic accuracy, avoiding the need to analyze every aspect of the diffraction pattern.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the development of low-cost, non-invasive diagnostic tests for early disease detection, providing reliable structural markers for diseases like cancer, improving prognosis through timely intervention.
Implementation Method 1
measuring a first molecular structure of the biological tissue of the first population of animals, after the carcinogenic or pathogenic substance was introduced into the first population of animals, using a biological tissue characterization technique
Implementation Method 2
low angle fiber X-ray diffraction techniques
Data Source
AI summary
The present disclosure relates to determining a biological tissue structural marker for diagnosis of a disease using a biological tissue characterization technique. A method for determining a structural marker for a diagnosis of a disease can include measuring a first molecular structure of a biological tissue of a first population of animals, after a carcinogenic or pathogenic substance was introduced into the first population. A second molecular structure of the biological tissue of a second population of animals can be measured, wherein the second population did not receive the carcinogenic or pathogenic substance. A first and a second structural marker of the molecular structures of the biological tissue of the first and second populations, respectively, can be identified and compared to determine that the first structural marker is indicative that the biological tissue of the first population of animals was affected by the disease.